Evaluation Frequency of Human Papillomavirus and Its Related Genotypes in Women of the General Population Living in 11 Provinces of Iran.


Journal

The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale
ISSN: 1712-9532
Titre abrégé: Can J Infect Dis Med Microbiol
Pays: Egypt
ID NLM: 101226876

Informations de publication

Date de publication:
2022
Historique:
received: 01 02 2022
accepted: 16 04 2022
entrez: 9 5 2022
pubmed: 10 5 2022
medline: 10 5 2022
Statut: epublish

Résumé

Persistent infection with one of the most high-risk genotypes of human papillomavirus causes all cases of cervical cancer and a significant proportion of other genital cancers. The HPV virus, unlike any other infection that leads to cancer, is transmitted only through sexual intercourse and is less affected by the general changes and development in lifestyle and medical standards, so only vaccination and screening can prevent the HPV virus and cancers caused by it. Therefore, determining the prevalence and distribution of HPV genotypes are of utmost importance in screening strategies regarding cervical cancer and vaccination decisions against HPV that vary based on the geographical and cultural characteristics of the study area. As a result, this study aimed to determine the frequency of human papillomavirus and the distribution of this virus's genotypes in the general population of women living in 11 provinces of Iran. This study is a community-based survey study. Sampling was done by the cluster sampling method. Women aged 15-59 years old from the general population living in 11 provinces of Iran were included in the study after considering the inclusion and exclusion criteria. Data were collected using a questionnaire and vaginal examination. The study was performed on 2562 vaginal specimens that were referred to the laboratory of the present study. HPV genome was detected by the nested MY-GP method and papillomavirus genotyping was performed using the PCR multiplex method to identify 19 papillomavirus genotypes. The general prevalence of HPV in the 11 provinces was obtained at 2.4% (108 out of 2562 people). The highest prevalence of the virus was in the age group of 25-34 years. The prevalence of HPV was statistically significant among different provinces. Hormozgan province with 22 cases (5.9%) had the highest and Isfahan province with 6 cases (2.2%) had the lowest incidence of HPV. The prevalence of high-risk HPV and medium-risk HPV is 3%, and the prevalence of low-risk HPV was estimated to be 2.1% of the total female population. Also, the highest prevalence was related to genotype 16. According to the high prevalence of the HPV virus in young age groups in Iran, it is necessary to pay attention to screening programs to reduce the incidence of cervical cancer.

Identifiants

pubmed: 35528803
doi: 10.1155/2022/8668557
pmc: PMC9072042
doi:

Types de publication

Journal Article

Langues

eng

Pagination

8668557

Informations de copyright

Copyright © 2022 Somayeh Hassani et al.

Déclaration de conflit d'intérêts

The authors declare that they have no conflicts of interest.

Références

Int J Infect Dis. 2018 Jan;66:83-89
pubmed: 29138009
Front Oncol. 2014 Mar 14;4:48
pubmed: 24672770
Int J Prev Med. 2016 May 04;7:70
pubmed: 27217936
Vaccine. 2006 Aug 31;24 Suppl 3:S3/52-61
pubmed: 16950018
Women Health. 2021 Jan;61(1):73-82
pubmed: 32957835
Intervirology. 2017;60(4):125-130
pubmed: 29393201
AIDS Behav. 2018 Jul;22(Suppl 1):19-25
pubmed: 29744768
J Adolesc Health. 2008 Oct;43(4 Suppl):S5-25, S25.e1-41
pubmed: 18809145
J Infect Dis. 2011 Aug 15;204(4):566-73
pubmed: 21791659
Vaccine. 2013 Dec 30;31 Suppl 6:G32-44
pubmed: 24331818
J Virol Methods. 2004 Dec 1;122(1):87-93
pubmed: 15488625
Papillomavirus Res. 2019 Jun;7:67-74
pubmed: 30738204
Arch Gynecol Obstet. 2012 Mar;285(3):771-7
pubmed: 22159694
BMC Infect Dis. 2011 Dec 02;11:333
pubmed: 22136570
Int J Cancer. 2015 Mar 1;136(5):E359-86
pubmed: 25220842
PLoS One. 2014 Jun 11;9(6):e99109
pubmed: 24918582
Oral Oncol. 2014 May;50(5):364-9
pubmed: 24080455
Int J Gynaecol Obstet. 2010 Mar;108(3):254-5
pubmed: 19951816
Infect Agent Cancer. 2018 Jan 25;13:6
pubmed: 29416557
Ann Oncol. 2011 Dec;22(12):2675-2686
pubmed: 21471563
Vaccine. 2013 Dec 31;31 Suppl 7:H46-58
pubmed: 24332297
BMC Cancer. 2014 Dec 17;14:968
pubmed: 25515630
J Infect Dis. 2014 Aug 1;210(3):448-55
pubmed: 24569064
Gynecol Oncol. 2013 Feb;128(2):277-81
pubmed: 23200918
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Vaccine. 2013 Dec 31;31 Suppl 7:H32-45
pubmed: 24332296
Int J Cancer. 2012 Jul 15;131(2):E156-61
pubmed: 22038830
PLoS One. 2011 May 03;6(5):e19244
pubmed: 21559276
Can J Infect Dis Med Microbiol. 2022 Jan 25;2022:4759871
pubmed: 35126798
PLoS Pathog. 2016 Jun 16;12(6):e1005613
pubmed: 27310012
Infect Agent Cancer. 2016 Apr 06;11:17
pubmed: 27053945
Vaccine. 2012 Nov 20;30 Suppl 5:F12-23
pubmed: 23199955

Auteurs

Somayeh Hassani (S)

Virology Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Proshat Sadat Nadji (PS)

Department of Microbiology, Faculty of Pharmacy and Pharmaceutical Sciences, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.

Anita Mohseni (A)

Virology Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Marjan Rahnamaye Farzami (M)

Reference Health Laboratory Research Center, Ministry of Health and Medical Education, Tehran, Iran.

Siamak Mirab Samiee (S)

Reference Health Laboratory Research Center, Ministry of Health and Medical Education, Tehran, Iran.

Makan Sadr (M)

Virology Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Seyed Alireza Nadji (SA)

Virology Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Classifications MeSH